Cancer cells in blood predict chances of survival and can help target breast cancer treatment

German doctors have found that breast cancer patients with at least five circulating tumor cells in their blood detected straight after surgery have a four-fold increase in the risk of recurrence and a three-fold increase in the risk of death. In addition to helping provide a more accurate evaluation of disease outcome, CTCs might also become targets for treatment in the future, they say.